Filed 4mo ago· Jan 15, 2026
28 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–79 of 79
Filed 4mo ago· Jan 13, 2026
36 days to disclose
Julia Letlow
RHouseLouisiana-05
↓sold
AbbVie
ABBV
$1K-$15K
−1.9% vs S&P 500
Trade dateDec 8, 2025
Filed 4mo ago· Jan 13, 2026
260 days to disclose · 215 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
AbbVie
ABBV
$1K-$15K
+6.5% vs S&P 500
Trade dateApr 28, 2025
Filed 4mo ago· Jan 13, 2026
354 days to disclose · 309 past 45-day windowJulia Letlow
RHouseLouisiana-05
↓sold
AbbVie
ABBV
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
AbbVie
ABBV
$1K-$15K
+17.6% vs S&P 500
Trade dateOct 23, 2024
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 6mo ago· Nov 21, 2025
21 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
AbbVie
ABBV
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
AbbVie
ABBV
$1K-$15K
−7.1% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
AbbVie
ABBV
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
AbbVie
ABBV
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Aug 20, 2025
40 days to disclose
Ritchie Torres
DHouseNew York-15
↓sold
AbbVie
ABBV
$1K-$15K
+9.9% vs S&P 500
Trade dateJul 11, 2025
Filed 9mo ago· Aug 20, 2025
328 days to disclose · 283 past 45-day windowRitchie Torres
DHouseNew York-15
↑bought
AbbVie
ABBV
$1K-$15K
−21.2% vs S&P 500
Trade dateSep 26, 2024
Filed 9mo ago· Aug 15, 2025
11 days to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
−2.3% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 13, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
AbbVie
ABBV
$1K-$15K
+11.2% vs S&P 500
Trade dateJul 22, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
AbbVie
ABBV
$1K-$15K
+5.6% vs S&P 500
Trade dateJul 22, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
57 days to disclose · 12 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
AbbVie
ABBV
$1K-$15K
+6.6% vs S&P 500
Trade dateJun 17, 2025
⚑ Pharmaceutical
Filed 11mo ago· Jun 11, 2025
20 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+6.0% vs S&P 500
Trade dateMay 22, 2025
Filed 11mo ago· Jun 9, 2025
25 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
AbbVie
ABBV
$1K-$15K
+4.1% vs S&P 500
Trade dateMay 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 14, 2025
27 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Filed 1.1y ago· May 14, 2025
41 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+4.7% vs S&P 500
Trade dateApr 3, 2025
Filed 1.1y ago· May 14, 2025
43 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+2.4% vs S&P 500
Trade dateApr 1, 2025
Filed 1.1y ago· May 9, 2025
32 days to disclose
Jared Moskowitz
DHouseFlorida-23
↑bought
AbbVie
ABBV
$1K-$15K
+6.8% vs S&P 500
Trade dateApr 7, 2025
Filed 1.1y ago· May 8, 2025
21 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
AbbVie
ABBV
$50K-$100K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
AbbVie
ABBV
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
+2.5% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· Apr 17, 2025
14 days to disclose
Dwight Evans
DHousePennsylvania-03
↓sold
AbbVie
ABBV
$1K-$15K
+3.8% vs S&P 500
Trade dateApr 3, 2025
⚑ Pharmaceutical
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
AbbVie
ABBV
$1K-$15K
+5.2% vs S&P 500
Trade dateFeb 25, 2025
⚑ Pharmaceutical
Filed 1.2y ago· Mar 19, 2025
2 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
−0.6% vs S&P 500
Trade dateMar 17, 2025
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
AbbVie
ABBV
$50K-$100K
+6.5% vs S&P 500
Trade dateFeb 24, 2025
Filed 1.3y ago· Feb 10, 2025
26 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
AbbVie
ABBV
$1K-$15K
+20.2% vs S&P 500
Trade dateJan 15, 2025
Filed 1.3y ago· Feb 10, 2025
26 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
AbbVie
ABBV
$1K-$15K
+20.2% vs S&P 500
Trade dateJan 15, 2025
Filed 1.4y ago· Jan 6, 2025
31 days to disclose
Virginia Foxx
RHouseNorth Carolina-05
↑bought
AbbVie
ABBV
$1K-$15K
+21.2% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.5y ago· Nov 21, 2024
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
+24.6% vs S&P 500
Trade dateNov 20, 2024
Filed 1.7y ago· Sep 6, 2024
2 days to disclose
John James
RHouseMichigan-10
↓sold
AbbVie
ABBV
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
AbbVie
ABBV
$1K-$15K
+40.1% vs S&P 500
Trade dateNov 10, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Aug 16, 2024
45 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$1K-$15K
+26.3% vs S&P 500
Trade dateJul 2, 2024
Filed 2.1y ago· May 2, 2024
22 days to disclose
Michael C. Burgess
—HouseTexas-26
↓sold
AbbVie
ABBV
$1K-$15K
+21.3% vs S&P 500
Trade dateApr 10, 2024
Filed 2.3y ago· Feb 6, 2024
5 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$500K-$1M
+23.4% vs S&P 500
Trade dateFeb 1, 2024
Filed 2.5y ago· Dec 18, 2023
10 days to discloseMichael C. Burgess
—HouseTexas-26
↓sold
AbbVie
ABBV
$1K-$15K
+22.0% vs S&P 500
Trade dateDec 8, 2023
Filed 2.5y ago· Dec 8, 2023
30 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+42.5% vs S&P 500
Trade dateNov 8, 2023
Filed 2.6y ago· Oct 19, 2023
21 days to disclose
Robert J. Wittman
RHouseVirginia-01
↓sold
AbbVie
ABBV
$1K-$15K
+14.5% vs S&P 500
Trade dateSep 28, 2023
Filed 2.6y ago· Oct 10, 2023
32 days to disclose
Lois Frankel
DHouseFlorida-22
↓sold
AbbVie
ABBV
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
Filed 2.6y ago· Oct 10, 2023
32 days to discloseLois Frankel
DHouseFlorida-22
↓sold
AbbVie
ABBV
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
Filed 2.6y ago· Oct 10, 2023
41 days to discloseLois Frankel
DHouseFlorida-22
↑bought
AbbVie
ABBV
$1K-$15K
+37.3% vs S&P 500
Trade dateAug 30, 2023
Filed 2.7y ago· Sep 5, 2023
27 days to discloseMichael C. Burgess
—HouseTexas-26
↑bought
AbbVie
ABBV
$15K-$50K
−28.4% vs S&P 500
Trade dateAug 9, 2023
Filed 2.8y ago· Aug 23, 2023
16 days to disclose
Michael Guest
RHouseMississippi-03
↑bought
AbbVie
ABBV
$1K-$15K
−25.6% vs S&P 500
Trade dateAug 7, 2023
Filed 2.8y ago· Aug 21, 2023
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+43.5% vs S&P 500
Trade dateJul 24, 2023
Filed 2.8y ago· Aug 13, 2023
32 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
AbbVie
ABBV
$50K-$100K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 2.8y ago· Aug 10, 2023
997 days to disclose · 952 past 45-day window
Rick W. Allen
RHouseGeorgia-12
↑bought
AbbVie
ABBV
$15K-$50K
Trade dateNov 16, 2020
⚑ Pharmaceutical
Filed 2.9y ago· Jul 18, 2023
12 days to discloseMichael C. Burgess
—HouseTexas-26
↑bought
AbbVie
ABBV
$15K-$50K
+43.3% vs S&P 500
Trade dateJul 6, 2023
Filed 2.9y ago· Jul 11, 2023
15 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+48.9% vs S&P 500
Trade dateJun 26, 2023
Filed 3.0y ago· Jun 11, 2023
32 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+11.8% vs S&P 500
Trade dateMay 10, 2023
Filed 3.0y ago· May 19, 2023
21 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$1K-$15K
+30.6% vs S&P 500
Trade dateApr 28, 2023
Filed 3.0y ago· May 19, 2023
21 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$1K-$15K
+11.2% vs S&P 500
Trade dateApr 28, 2023
Filed 3.0y ago· May 19, 2023
21 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$1K-$15K
+11.2% vs S&P 500
Trade dateApr 28, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
AbbVie
ABBV
$1K-$15K
+11.3% vs S&P 500
Trade dateApr 10, 2023
Filed 3.1y ago· Apr 20, 2023
27 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+16.7% vs S&P 500
Trade dateMar 24, 2023
Filed 3.1y ago· Apr 20, 2023
45 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+25.8% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
AbbVie
ABBV
$1K-$15K
+23.0% vs S&P 500
Trade dateMar 6, 2023
Filed 3.2y ago· Mar 17, 2023
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+31.7% vs S&P 500
Trade dateFeb 10, 2023
Filed 3.2y ago· Mar 17, 2023
38 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+11.8% vs S&P 500
Trade dateFeb 7, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
AbbVie
ABBV
$1K-$15K
+11.4% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 17, 2023
17 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+36.6% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 17, 2023
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+10.9% vs S&P 500
Trade dateJan 20, 2023
Filed 3.6y ago· Oct 11, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$1K-$15K
+13.0% vs S&P 500
Trade dateSep 12, 2022
Filed 3.8y ago· Aug 19, 2022
14 days to discloseDwight Evans
DHousePennsylvania-03
↑bought
AbbVie
ABBV
$1K-$15K
+42.3% vs S&P 500
Trade dateAug 5, 2022
⚑ Pharmaceutical
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$15K-$50K
+12.5% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$1K-$15K
+29.3% vs S&P 500
Trade dateJul 27, 2022
Filed 3.8y ago· Aug 10, 2022
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
AbbVie
ABBV
$1K-$15K
+29.3% vs S&P 500
Trade dateJul 27, 2022
Filed 3.9y ago· Jul 8, 2022
22 days to discloseRobert J. Wittman
RHouseVirginia-01
↑bought
AbbVie
ABBV
$1K-$15K
+31.2% vs S&P 500
Trade dateJun 16, 2022
Filed 4.1y ago· Apr 19, 2022
34 days to disclose
John H. Rutherford
RHouseFlorida-05
↓sold
AbbVie
ABBV
$1K-$15K
+10.8% vs S&P 500
Trade dateMar 16, 2022
Filed 4.1y ago· Apr 17, 2022
31 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
+28.8% vs S&P 500
Trade dateMar 17, 2022
Filed 4.1y ago· Apr 17, 2022
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
+12.1% vs S&P 500
Trade dateMar 15, 2022
Filed 4.2y ago· Mar 18, 2022
35 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
Trade dateFeb 11, 2022
Filed 4.2y ago· Mar 18, 2022
37 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
AbbVie
ABBV
$1K-$15K
Trade dateFeb 9, 2022
Filed 4.3y ago· Feb 18, 2022
18 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
AbbVie
ABBV
$1K-$15K
Trade dateJan 31, 2022
Filed 4.5y ago· Nov 28, 2021
2 days to disclose
Bob Gibbs
—HouseOhio-07
↑bought
AbbVie
ABBV
$1K-$15K
+15.0% vs S&P 500
Trade dateNov 26, 2021
Filed 5.0y ago· Jun 21, 2021
5 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
AbbVie
ABBV
$1K-$15K
+2.9% vs S&P 500
Trade dateJun 16, 2021
Filed 5.1y ago· May 6, 2021
6 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
AbbVie
ABBV
$1K-$15K
−7.1% vs S&P 500
Trade dateApr 30, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | AbbVie ABBV | Dec 8, 2025 36 days to disclose | Flat·+0.0% −1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | AbbVie ABBV | Apr 28, 2025 260 days to disclose · 215 past 45-day window | Good buy·+$1.1K+13.7% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | AbbVie ABBV | Jan 24, 2025 354 days to disclose · 309 past 45-day window | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | AbbVie ABBV | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Good buy·+$1.3K+16.4% +17.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Bad buy·−$335-4.2% −7.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | AbbVie ABBV | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↓sold | AbbVie ABBV | Jul 11, 2025 40 days to disclose | Flat·+0.0% +9.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↑bought | AbbVie ABBV | Sep 26, 2024 328 days to disclose · 283 past 45-day window | Good buy·+$284+3.5% −21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Aug 4, 2025 11 days to disclose | Good buy·+$749+9.4% −2.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 22, 2025 22 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 22, 2025 22 days to disclose | Good buy·+$1.3K+16.9% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Good buy·+$1.4K+17.9% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | May 22, 2025 20 days to disclose | Good buy·+$1.6K+19.8% +6.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 11mo ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 25 days to disclose | Good buy·+$1.4K+18.0% +4.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Apr 17, 2025 27 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Apr 3, 2025 41 days to disclose | Good buy·+$675+8.4% +4.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Apr 1, 2025 43 days to disclose | Good buy·+$480+6.0% +2.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 9, 2025 1.1y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Apr 7, 2025 32 days to disclose | Good buy·+$1.4K+17.2% +6.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | AbbVie ABBV | Apr 17, 2025 21 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $50K-$100K midpoint $75K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | May 5, 2025 1 day to disclose | Good buy·+$799+10.0% +2.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2025 1.1y ago | Dwight Evans DHousePennsylvania-03 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Ways and Means | Apr 3, 2025 14 days to disclose | Flat·+0.0% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Good buy·+$399+5.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 19, 2025 1.2y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Mar 17, 2025 2 days to disclose | Good buy·+$44+0.6% −0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | AbbVie ABBV | Feb 24, 2025 13 days to disclose | Good buy·+$5.4K+7.1% +6.5% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 10, 2025 1.3y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Jan 15, 2025 26 days to disclose | Good buy·+$2.1K+25.9% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Jan 15, 2025 26 days to disclose | Good buy·+$2.1K+25.9% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$1.9K+24.1% +21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2024 1.5y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Nov 20, 2024 1 day to disclose | Good buy·+$2.3K+28.5% +24.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$4.6K+57.8% +40.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Jul 2, 2024 45 days to disclose | Good buy·+$2.3K+29.1% +26.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2024 2.1y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | AbbVie ABBV | Apr 10, 2024 22 days to disclose | Missed gain·−$1.4K-17.6% +21.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Feb 1, 2024 5 days to disclose | Good buy·+$209.1K+27.9% +23.4% vs S&P 500 | $500K-$1M midpoint $750K |
Dec 18, 2023 2.5y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | AbbVie ABBV | Dec 8, 2023 10 days to disclose | Missed gain·−$2.6K-33.1% +22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2023 2.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Nov 8, 2023 30 days to disclose | Good buy·+$4.7K+58.4% +42.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 19, 2023 2.6y ago | Robert J. Wittman RHouseVirginia-01 | ↓sold | AbbVie ABBV | Sep 28, 2023 21 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | AbbVie ABBV | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | AbbVie ABBV | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↑bought | AbbVie ABBV | Aug 30, 2023 41 days to disclose | Good buy·+$3.8K+47.4% +37.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 5, 2023 2.7y ago | Michael C. Burgess —HouseTexas-26 | ↑bought | AbbVie ABBV | Aug 9, 2023 27 days to disclose | Good buy·+$10.3K+31.8% −28.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 23, 2023 2.8y ago | Michael Guest RHouseMississippi-03 | ↑bought | AbbVie ABBV | Aug 7, 2023 16 days to disclose | Good buy·+$2.6K+32.7% −25.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2023 2.8y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Jul 24, 2023 28 days to disclose | Good buy·+$4.2K+52.7% +43.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | AbbVie ABBV | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Nov 16, 2020 997 days to disclose · 952 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Jul 18, 2023 2.9y ago | Michael C. Burgess —HouseTexas-26 | ↑bought | AbbVie ABBV | Jul 6, 2023 12 days to disclose | Good buy·+$18.6K+57.1% +43.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 11, 2023 2.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Jun 26, 2023 15 days to disclose | Good buy·+$5K+62.0% +48.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2023 3.0y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | May 10, 2023 32 days to disclose | Flat·+0.0% +11.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Apr 28, 2023 21 days to disclose | Good buy·+$3.3K+41.8% +30.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Apr 28, 2023 21 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Apr 28, 2023 21 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | AbbVie ABBV | Apr 10, 2023 39 days to disclose | Flat·+0.0% +11.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Mar 24, 2023 27 days to disclose | Flat·+0.0% +16.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 20, 2023 3.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Mar 6, 2023 45 days to disclose | Good buy·+$3.3K+40.8% +25.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | AbbVie ABBV | Mar 6, 2023 42 days to disclose | Good buy·+$3K+38.0% +23.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 17, 2023 3.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Feb 10, 2023 35 days to disclose | Good buy·+$3.5K+43.8% +31.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 17, 2023 3.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Feb 7, 2023 38 days to disclose | Flat·+0.0% +11.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | AbbVie ABBV | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 17, 2023 3.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Jan 31, 2023 17 days to disclose | Good buy·+$3.8K+48.0% +36.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 17, 2023 3.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Jan 20, 2023 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Sep 12, 2022 29 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 19, 2022 3.8y ago | Dwight Evans DHousePennsylvania-03 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Ways and Means | Aug 5, 2022 14 days to disclose | Good buy·+$4.4K+55.3% +42.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Jul 27, 2022 14 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Jul 27, 2022 14 days to disclose | Good buy·+$3.3K+41.8% +29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | AbbVie ABBV | Jul 27, 2022 14 days to disclose | Good buy·+$3.3K+41.8% +29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 8, 2022 3.9y ago | Robert J. Wittman RHouseVirginia-01 | ↑bought | AbbVie ABBV | Jun 16, 2022 22 days to disclose | Good buy·+$4.4K+55.0% +31.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 19, 2022 4.1y ago | John H. Rutherford RHouseFlorida-05 | ↓sold | AbbVie ABBV | Mar 16, 2022 34 days to disclose | Flat·+0.0% +10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2022 4.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Mar 17, 2022 31 days to disclose | Good buy·+$3K+37.9% +28.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2022 4.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Mar 15, 2022 33 days to disclose | Flat·+0.0% +12.1% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 18, 2022 4.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Feb 11, 2022 35 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 18, 2022 4.2y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | AbbVie ABBV | Feb 9, 2022 37 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 18, 2022 4.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | AbbVie ABBV | Jan 31, 2022 18 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 28, 2021 4.5y ago | Bob Gibbs —HouseOhio-07 | ↑bought | AbbVie ABBV | Nov 26, 2021 2 days to disclose | Good buy·+$5.6K+70.6% +15.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 21, 2021 5.0y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Jun 16, 2021 5 days to disclose | Good buy·+$5.8K+72.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2021 5.1y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | AbbVie ABBV | Apr 30, 2021 6 days to disclose | Missed gain·−$6.3K-78.2% −7.1% vs S&P 500 | $1K-$15K midpoint $8K |